Background and Objective: Impairment in cognitive domains occurs commonly in
INTRODUCTION
Tramadol has a dual mechanism of action. Tramadol and its active metabolite, O-desmethyl tramadol, bind to μ opioid receptors, thus exerting their effect on GABAergic transmission. They also inhibit reuptake of 5-hydroxy tryptamine (serotonin) and noradrenaline (Shadnia, et al.
2008, and Taghaddosinejad, et al. 2011).
Few works studied the cognitive profile of tramadol dependence however, many studies were done regarding the cognitive profile of other substances of abuse particularly the opioids and cannabis. This can be explained by that tramadol is not a very common drug in the western world and does not represent a medical issue of importance regarding dependence to be a focus for the scientific research unlike in Egypt where it represents a major health issue (Abo-Elmagd, et al. 2013).
SUBJECS AND METHODS Subjects
This study compares between two groups regarding attention and memory. The first group is composed of 30 patients with two years or more of regular tramadol abuse (Dependency). The second group is a control group of 30 persons from relatives of the first and second group who are matched with them regarding age, sex and educational level. Table ( 2) shows significant difference between the two groups in subscore delayed recall. Table ( 3) shows no significant difference between the two groups Trail making A and B scores. 
RESULTS
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